These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11600356)

  • 61. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.
    Vidal S; Tremblay ML; Govoni G; Gauthier S; Sebastiani G; Malo D; Skamene E; Olivier M; Jothy S; Gros P
    J Exp Med; 1995 Sep; 182(3):655-66. PubMed ID: 7650477
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular mechanisms of natural resistance to mycobacterial infections.
    Radzioch D; Kramnik I; Skamene E
    Circ Shock; 1994 Nov; 44(3):115-20. PubMed ID: 7600634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609.
    Gibson SJ; Imbertson LM; Wagner TL; Testerman TL; Reiter MJ; Miller RL; Tomai MA
    J Interferon Cytokine Res; 1995 Jun; 15(6):537-45. PubMed ID: 7553223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways.
    Megyeri K; Au WC; Rosztoczy I; Raj NB; Miller RL; Tomai MA; Pitha PM
    Mol Cell Biol; 1995 Apr; 15(4):2207-18. PubMed ID: 7534379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytokine induction in mice by the immunomodulator imiquimod.
    Reiter MJ; Testerman TL; Miller RL; Weeks CE; Tomai MA
    J Leukoc Biol; 1994 Feb; 55(2):234-40. PubMed ID: 7507969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Letter: Genetic control of natural resistance to Leishmania donovani.
    Bradley DJ
    Nature; 1974 Jul; 250(464):353-4. PubMed ID: 4852791
    [No Abstract]   [Full Text] [Related]  

  • 67. Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.
    Bernstein DI; Harrison CJ
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1511-5. PubMed ID: 2479335
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection.
    Harrison CJ; Jenski L; Voychehovski T; Bernstein DI
    Antiviral Res; 1988 Dec; 10(4-5):209-23. PubMed ID: 2465735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular genetics of inherited susceptibility to intracellular parasites.
    Schurr E; Radzioch D; Malo D; Gros P; Skamene E
    Behring Inst Mitt; 1991 Feb; (88):1-12. PubMed ID: 1675564
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
    Harrison CJ; Stanberry LR; Bernstein DI
    Antiviral Res; 1991 May; 15(4):315-22. PubMed ID: 1659313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.
    Sidky YA; Borden EC; Weeks CE; Reiter MJ; Hatcher JF; Bryan GT
    Cancer Res; 1992 Jul; 52(13):3528-33. PubMed ID: 1377595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).
    Moisan J; Wojciechowski W; Guilbault C; Lachance C; Di Marco S; Skamene E; Matlashewski G; Radzioch D
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3059-64. PubMed ID: 11600356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonspecific resistance to Mycobacteria: the role of the Nramp1 gene.
    Buschman E; Vidal S; Skamene E
    Behring Inst Mitt; 1997 Mar; (99):51-7. PubMed ID: 9303202
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus.
    Vidal S; Gros P; Skamene E
    J Leukoc Biol; 1995 Oct; 58(4):382-90. PubMed ID: 7561513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens.
    Green SJ; Scheller LF; Marletta MA; Seguin MC; Klotz FW; Slayter M; Nelson BJ; Nacy CA
    Immunol Lett; 1994 Dec; 43(1-2):87-94. PubMed ID: 7537721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility.
    Blackwell JM
    Mol Med Today; 1996 May; 2(5):205-11. PubMed ID: 8796889
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Macrophage NRAMP1 and its role in resistance to microbial infections.
    Govoni G; Gros P
    Inflamm Res; 1998 Jul; 47(7):277-84. PubMed ID: 9719491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis.
    Fortin A; Abel L; Casanova JL; Gros P
    Annu Rev Genomics Hum Genet; 2007; 8():163-92. PubMed ID: 17492906
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens.
    Bellamy R
    Microbes Infect; 1999 Jan; 1(1):23-7. PubMed ID: 10594973
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.